SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-037859
Filing Date
2017-07-24
Accepted
2017-07-24 16:41:07
Documents
8
Period of Report
2017-09-07
Effectiveness Date
2017-07-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A v470883_def14a.htm DEF 14A 819430
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC sig_jcook.jpg GRAPHIC 20197
4 GRAPHIC spacer.gif GRAPHIC 43
5 GRAPHIC v470883_pc1.jpg GRAPHIC 1033275
6 GRAPHIC v470883_pc2.jpg GRAPHIC 654887
7 GRAPHIC v470883_pc3.jpg GRAPHIC 568055
8 GRAPHIC v470883_pc4.jpg GRAPHIC 643450
  Complete submission text file 0001144204-17-037859.txt   4842147
Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130
Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 17978646
SIC: 2836 Biological Products, (No Diagnostic Substances)